Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak L Bhatt

Showing results (1021-1030 of 1,708) with videos related to

Pageof 171
Sort By:
Journal of Thrombosis and Thrombolysis|June 2, 2012
Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD programMichelle L O'Donoghue, Deepak L Bhatt, Marcus D Flather, et al.
JAMA Cardiology|September 30, 2016
Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical TrialBenjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, et al.
European Heart Journal|March 29, 2023
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleedingDavide Cao, Nicolas Amabile, Mauro Chiarito, et al.
Diabetes Care|March 12, 2015
Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trialLawrence A Leiter, Hwee Teoh, Eugene Braunwald, et al.
Journal of Clinical Lipidology|June 7, 2025
Estimate and prognosis of patients who are candidates for treatment with eicosapentaenoic acid after an acute coronary syndromeAlberto Cordero, José R Gonzalez-Juanatey, Rosa Fernandez Olmo, et al.
RMD Open|April 12, 2024
Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety studyMaya H Buch, Deepak L Bhatt, Christina Charles-Schoeman, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Correlation Between Periprocedural Myocardial Infarction, Mortality, and Quality of Life in Coronary Revascularization Trials: A Meta-analysisMario Gaudino, Antonino Di Franco, Arnaldo Dimagli, et al.
Circulation|September 1, 2010
Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) RegistrySripal Bangalore, Deepak L Bhatt, Joachim Röther, et al.
Stroke|October 28, 2006
Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the Reduction of Atherothrombosis for Continued Health (REACH) registryEmmanuel Touzé, Jean-Louis Mas, Joachim Röther, et al.
JAMA|March 22, 2007
One-year cardiovascular event rates in outpatients with atherothrombosisPh Gabriel Steg, Deepak L Bhatt, Peter W F Wilson, et al.
Pageof 171

Showing results (1021-1030 of 1,708) with videos related to

Sort By:
Pageof 171
Journal of Thrombosis and Thrombolysis|June 2, 2012
Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD programMichelle L O'Donoghue, Deepak L Bhatt, Marcus D Flather, et al.
JAMA Cardiology|September 30, 2016
Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical TrialBenjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, et al.
European Heart Journal|March 29, 2023
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleedingDavide Cao, Nicolas Amabile, Mauro Chiarito, et al.
Diabetes Care|March 12, 2015
Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trialLawrence A Leiter, Hwee Teoh, Eugene Braunwald, et al.
Journal of Clinical Lipidology|June 7, 2025
Estimate and prognosis of patients who are candidates for treatment with eicosapentaenoic acid after an acute coronary syndromeAlberto Cordero, José R Gonzalez-Juanatey, Rosa Fernandez Olmo, et al.
RMD Open|April 12, 2024
Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety studyMaya H Buch, Deepak L Bhatt, Christina Charles-Schoeman, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Correlation Between Periprocedural Myocardial Infarction, Mortality, and Quality of Life in Coronary Revascularization Trials: A Meta-analysisMario Gaudino, Antonino Di Franco, Arnaldo Dimagli, et al.
Circulation|September 1, 2010
Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) RegistrySripal Bangalore, Deepak L Bhatt, Joachim Röther, et al.
Stroke|October 28, 2006
Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the Reduction of Atherothrombosis for Continued Health (REACH) registryEmmanuel Touzé, Jean-Louis Mas, Joachim Röther, et al.
JAMA|March 22, 2007
One-year cardiovascular event rates in outpatients with atherothrombosisPh Gabriel Steg, Deepak L Bhatt, Peter W F Wilson, et al.
Pageof 171